BIOMAT Database Logo BIOMAT Database Logo

Heterogeneity of human factor VIII. II. Characterization of forms of factor VIII binding to platelets in the presence of ristocetin. 1978

M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser

UI MeSH Term Description Entries
D007123 Immunoelectrophoresis, Two-Dimensional Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis. Immunoelectrophoresis, Crossed,Immunoelectrophoresis, 2-D,Immunoelectrophoresis, 2D,2-D Immunoelectrophoresis,2D Immunoelectrophoresis,Crossed Immunoelectrophoresis,Immunoelectrophoresis, 2 D,Immunoelectrophoresis, Two Dimensional,Two-Dimensional Immunoelectrophoresis
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Binding of factor VIII to platelets in the presence of ristocetin.
April 1977, British journal of haematology,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Binding of porcine von Willebrand factor to human platelets in the presence of ristocetin.
June 1982, Thrombosis research,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
September 1979, British journal of haematology,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Studies on the pathophysiology and treatment of von Willebrand's disease. III. Binding of plasma factor VIII to platelets in the presence of ristocetin.
July 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Binding of thrombin-activated human factor VIII to platelets.
November 1986, British journal of haematology,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
The binding of purified factor VIII to platelets.
January 1988, Progress in clinical and biological research,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Selective binding of the factor VIII/von Willebrand factor protein to human platelets.
January 1980, Blood,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
In vivo and in vitro binding of factor VIII to human platelets.
February 1969, Thrombosis et diathesis haemorrhagica,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates.
January 1987, Vox sanguinis,
M H Doucet-de Bruïne, and J J Sixma, and J Over, and N H Beeser-Visser
Factor VIII influences binding of factor IX and factor X to intact human platelets.
September 1989, Thrombosis research,
Copied contents to your clipboard!